| Literature DB >> 8919313 |
S Consolo1, S Ramponi, H Ladinsky, G Baldi.
Abstract
Subcutaneous administration of 8-OH-DPAT dose-dependently increased acetylcholine (ACh) output in frontal cortex of awake rats. The maximal effect of 8-OH-DPAT (0.5 mg/kg, s.c.) was prevented by the 5-HT1A antagonist WAY 100635 (1 mg/kg, s.c.) and by the D1 antagonists SCH 23390 or SCH 39166 (both 0.3 mg/kg, s.c.) but not seven days after chemical lesion of the raphe serotoninergic neurons. It is postulated that the 8-OH-DPAT activation of postsynaptic 5-HT1A receptors enhances the release of dopamine which, by acting at D1 receptors, stimulates the release of ACh in the frontal cortex.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8919313 DOI: 10.1016/0006-8993(95)01369-5
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252